282 related articles for article (PubMed ID: 20680030)
21. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
[TBL] [Abstract][Full Text] [Related]
22. Progesterone initiates Wnt-beta-catenin signaling but estradiol is required for nuclear activation and synchronous proliferation of rat uterine stromal cells.
Rider V; Isuzugawa K; Twarog M; Jones S; Cameron B; Imakawa K; Fang J
J Endocrinol; 2006 Dec; 191(3):537-48. PubMed ID: 17170212
[TBL] [Abstract][Full Text] [Related]
23. The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling.
Park CH; Hahm ER; Park S; Kim HK; Yang CH
FEBS Lett; 2005 May; 579(13):2965-71. PubMed ID: 15893313
[TBL] [Abstract][Full Text] [Related]
24. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
Liu S; Vinall RL; Tepper C; Shi XB; Xue LR; Ma AH; Wang LY; Fitzgerald LD; Wu Z; Gandour-Edwards R; deVere White RW; Kung HJ
Oncogene; 2008 Jan; 27(4):499-505. PubMed ID: 17653089
[TBL] [Abstract][Full Text] [Related]
25. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.
Baryawno N; Sveinbjörnsson B; Eksborg S; Chen CS; Kogner P; Johnsen JI
Cancer Res; 2010 Jan; 70(1):266-76. PubMed ID: 20028853
[TBL] [Abstract][Full Text] [Related]
26. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
27. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.
Yang X; Chen MW; Terry S; Vacherot F; Chopin DK; Bemis DL; Kitajewski J; Benson MC; Guo Y; Buttyan R
Cancer Res; 2005 Jun; 65(12):5263-71. PubMed ID: 15958572
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
29. Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling.
Bi X; Zhao Y; Fang W; Yang W
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1074-8. PubMed ID: 19413587
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms.
Kim WB; Lewis CJ; McCall KD; Malgor R; Kohn AD; Moon RT; Kohn LD
J Endocrinol; 2007 Apr; 193(1):93-106. PubMed ID: 17400807
[TBL] [Abstract][Full Text] [Related]
31. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
32. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells.
Su Y; Simmen RC
Carcinogenesis; 2009 Feb; 30(2):331-9. PubMed ID: 19073877
[TBL] [Abstract][Full Text] [Related]
33. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
Shankar S; Srivastava RK
Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
[TBL] [Abstract][Full Text] [Related]
34. Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer.
Udhayakumar G; Jayanthi V; Devaraj N; Devaraj H
Mol Carcinog; 2007 Sep; 46(9):807-17. PubMed ID: 17393422
[TBL] [Abstract][Full Text] [Related]
35. Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.
Liss MA; Schlicht M; Kahler A; Fitzgerald R; Thomassi T; Degueme A; Hessner M; Datta MW
Cancer Genomics Proteomics; 2010; 7(5):245-52. PubMed ID: 20952759
[TBL] [Abstract][Full Text] [Related]
36. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity.
Truica CI; Byers S; Gelmann EP
Cancer Res; 2000 Sep; 60(17):4709-13. PubMed ID: 10987273
[TBL] [Abstract][Full Text] [Related]
37. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
39. Curcumin suppresses proliferation and induces apoptosis of human hepatocellular carcinoma cells via the wnt signaling pathway.
Xu MX; Zhao L; Deng C; Yang L; Wang Y; Guo T; Li L; Lin J; Zhang L
Int J Oncol; 2013 Dec; 43(6):1951-9. PubMed ID: 24064724
[TBL] [Abstract][Full Text] [Related]
40. Curcumin suppresses cell proliferation through inhibition of the Wnt/β-catenin signaling pathway in medulloblastoma.
He M; Li Y; Zhang L; Li L; Shen Y; Lin L; Zheng W; Chen L; Bian X; Ng HK; Tang L
Oncol Rep; 2014 Jul; 32(1):173-80. PubMed ID: 24858998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]